Stoke Therapeutics Inc
STOK
Market Cap$609.25M
Close$
$4.37
62.3% downside
Current Fair Value
62.3% downsideOvervalued by 62.3% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $609.25 Million |
|---|---|
| Enterprise Value | $407.86 Million |
| Dividend Yield | $0.0 (0.0%) |
| Earnings per Share | $-2.38 |
| Beta | 1.84 |
| Outstanding Shares | 52,117,499 |
| Avg 30 Day Volume | 957,759 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -5.82 |
|---|---|
| PEG | -114.57 |
| Price to Sales | - |
| Price to Book Ratio | 3.87 |
| Enterprise Value to Revenue | 46.45 |
| Enterprise Value to EBIT | -3.55 |
| Enterprise Value to Net Income | -4 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0 |
Revenue Sources
No data
ESG Score
No data
About Stoke Therapeutics Inc
CEO: Edward Kaye